Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

Clinical trial NCT06087120 · RECRUITING

Trial details

NCT number: NCT06087120
Sponsor: Gene Solutions
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Female Stage II Breast Cancer Stage III Breast Cancer HER2-positive Breast Cancer Triple Negative Breast Cancer

Start date: 2023-09-16
Primary completion: 2025-12-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.